Ampio sags after OA candidate's latest miss

Ampio Pharmaceuticals Inc. (NYSE-M:AMPE) fell $2.03 (61%) to $1.29 on Thursday after Ampion

Read the full 138 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE